Skip to main content
The Bright Side
arrow_backHome
Genetic information changes the choice of treatment for prostate cancer
Health
Ynet HealthHE
October 4, 2026

Genetic information changes the choice of treatment for prostate cancer

In recent years, treatment for prostate cancer is changing: in addition to the disease stage and the extent of its spread, doctors are increasingly also examining the genetic characteristics of the tumor. This information allows identification of different subtypes of the disease and tailoring targeted therapies for some patients. New research supports integrating such treatments already at an earlier stage of the aggressive disease. Dr. Avivit Par, Rambam explains what has already changed, what the studies teach, and why caution is still required in decision-making.

Read More
translateRead translated

Automatic translation by Google

Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More ›
Ynet Health10/12/2026

A claim denial does not necessarily stem from medical ineligibility

What should you do when a doctor recommends a critical and expensive medication that is not included in the public health basket, but the insurance company rejects the request, claiming the insurance policy lacks coverage? Before you exhaust savings or break down over a denial letter from the insurer, it is important to understand the financing mechanisms operating behind the scenes. A guide to exercising patient rights in Israel.